H2AC1 (Histone H2A Clustered Member 1)
A core histone protein gene involved in chromatin structure and gene regulation
Gene Information Card
| Symbol | H2AC1 |
|---|---|
| Full Name | H2A clustered histone 1 |
| Gene Type | protein-coding |
| Chromosomal Location | 6p22.2 |
| NCBI Gene ID | 8326 ncbi.nlm.nih.gov/gene/8326 |
| Ensembl ID | ENSG00000274750 |
| UniProt ID | P0C0S8 |
| OMIM ID | 602786 |
| HGNC ID | 18765 |
| Aliases | HIST1H2AA, H2A histone family member A, H2A.1A |
Description
H2AC1 (H2A clustered histone 1) is a protein-coding gene located on chromosome 6p22.2. It encodes a replication-dependent histone H2A protein, a core component of the nucleosome. Histone H2A plays a central role in chromatin structure and gene regulation by packaging DNA into nucleosomes. H2AC1 is part of the histone H2A family, which includes multiple variants with distinct functions. The protein contains a conserved histone fold domain and a C-terminal tail that is subject to post-translational modifications, influencing chromatin dynamics and gene expression.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer | Altered expression and mutations in histone H2A genes, including H2AC1, can disrupt chromatin structure and gene expression, contributing to tumorigenesis. | COSMIC database lists somatic mutations in H2AC1 across various cancer types; ClinVar reports variants associated with oncogenic phenotypes. |
| Immunodeficiency | Mutations in histone genes may affect immune cell development and function, though direct evidence for H2AC1 is limited. | ClinVar includes variants in H2AC1 linked to immune-related conditions, but further studies are needed. |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | 12.3 | High |
| Bone Marrow | 8.7 | Medium |
| Lymph Node | 7.2 | Medium |
| Spleen | 6.5 | Medium |
| Brain | 2.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| K562 | 15.4 | High expression in leukemia cell line |
| HeLa | 10.2 | Moderate expression |
| A549 | 8.9 | Moderate expression |
| HepG2 | 6.3 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G (p.Met1Val) | Missense | 0.01% | Potential loss of start codon, affecting protein translation |
| c.100C>T (p.Arg34Cys) | Missense | 0.02% | May alter histone fold domain, affecting nucleosome stability |
| c.200A>G (p.Lys67Arg) | Missense | 0.005% | Possible impact on post-translational modification sites |
Mutation functional classification
Loss of Function (LOF)
Loss-of-function mutations in H2AC1 are rare and may lead to reduced histone H2A availability, affecting chromatin assembly and gene regulation.
Gain of Function (GOF)
Gain-of-function mutations are not well characterized; some missense variants may alter histone-DNA interactions, potentially affecting chromatin dynamics.
Dominant Negative (DN)
Dominant-negative effects are possible if mutant H2A proteins incorporate into nucleosomes and disrupt chromatin structure, but evidence is limited.
View complete mutation data:
Gene Ontology (GO)
| • DNA binding | • protein heterodimerization activity |
| • nucleosome assembly | • chromatin organization |
| • nucleus | • chromosome |
Pathways
• Packaging Of Telomere Ends
• Chromatin organization
• Nucleosome assembly
Protein Summary
The H2AC1 protein is a 130-amino acid histone H2A variant that forms part of the nucleosome core. It contains a histone fold domain that mediates dimerization with histone H2B and interaction with DNA. The protein undergoes various post-translational modifications, including acetylation, methylation, and phosphorylation, which regulate chromatin structure and gene expression. H2AC1 is expressed in proliferating cells and is essential for DNA replication and repair.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| H2AC11 Knockout HEK293 Cell Line | EDJ-KQ6415 | Human | 8969 | Details Get a Quote |
| H2AC1 Knockout HEK293 Cell Line | EDJ-KQ8858 | Human | 221613 | Details Get a Quote |
| H2AC19 Knockout HEK293 Cell Line | EDJ-KQ13705 | Human | 723790 | Details Get a Quote |
| H2AC11 Knockout A-549 Cell Line | EDJ-KQ30458 | Human | 8969 | Details Get a Quote |
| H2AC11 Knockout HCT 116 Cell Line | EDJ-KQ30459 | Human | 8969 | Details Get a Quote |
| H2AC11 Knockout HeLa Cell Line | EDJ-KQ30460 | Human | 8969 | Details Get a Quote |
| H2AC19 Knockout A-549 Cell Line | EDJ-KQ43428 | Human | 723790 | Details Get a Quote |
| H2AC19 Knockout HCT 116 Cell Line | EDJ-KQ43429 | Human | 723790 | Details Get a Quote |
| H2AC19 Knockout HeLa Cell Line | EDJ-KQ43430 | Human | 723790 | Details Get a Quote |
| H2AC13 Knockout HEK293 Cell Line | EDJ-KQ50752 | Human | 8329 | Details Get a Quote |
| H2AC15 Knockout HEK293 Cell Line | EDJ-KQ50753 | Human | 8330 | Details Get a Quote |
| H2AC16 Knockout HEK293 Cell Line | EDJ-KQ50754 | Human | 8332 | Details Get a Quote |
| H2AC17 Knockout HEK293 Cell Line | EDJ-KQ50757 | Human | 8336 | Details Get a Quote |
| H2AC12 Knockout HEK293 Cell Line | EDJ-KQ51874 | Human | 85235 | Details Get a Quote |
| H2AC13 Knockout HeLa Cell Line | EDJ-KQ54857 | Human | 8329 | Details Get a Quote |
- 1
- 2
- Next Page »